Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Removing Transfusion Dependence As a Barrier to Hospice Enrollment (BRUOG-407)

Pamela C Egan, Aryeh Pelcovits, Thomas W. Leblanc, Caitlyn Krar, Stephen Donnelly, Lila Rubin, Adam Olszewski, John L Reagan, Rabin Niroula

Blood (2022) 140 (Supplement 1): 7946–7947.

https://doi.org/10.1182/blood-2022-156951

Published: 2022

Journal Articles

Whole Genome Sequencing Identifies a Recurrent Mutation in Complement Factor I ( CFI ) in Primary Myelofibrosis (PMF)

Brooke Sadler, Anna D Chorzalska, Dennis M Bonal, Gabe Haller, Alissa Oakes, Max Petersen, Yuchen Liu, Adam Olszewski, John L Reagan, Pamela C Egan, Rabin Niroula, Diana O Treaba, Gabriela Hobbs, Stephen T. Oh, Jorge Di Paola, Joanna E Baxter, Patrycja M Dubielecka

Blood (2021) 138 (Supplement 1): 1472.

https://doi.org/10.1182/blood-2021-154281

Published: 2021

Journal Articles

Tumor Lysis Syndrome Risk in Outpatient Versus Inpatient Administration of Venetoclax and Hypomethlators for Acute Myeloid Leukemia

Aryeh Pelcovits, MD, Brianna Bakow, MD, Jozal Waroich, Pamela C Egan, MD, Rabin Niroula, MBBS, Adam J Olszewski, MD, John L Reagan, MD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-133880

Published: 2020

Journal Articles

Cerebrospinal Fluid (CSF) Analysis of Tumor-Specific Cell-Free DNA (cfDNA) As a Diagnostic and Prognostic Tool for Central Nervous System (CNS) Invasion in Lymphoma

Adam J Olszewski, MD, Anna D Chorzalska, PhD, Max Petersen, Thomas A Ollila, MD, Adam Zayac, MD, Habibe Kurt, MD, Diana O Treaba, MD, John L Reagan, MD, Andrew Hsu, MD, Pamela C Egan, MD, James Butera, MD, William Rafelson, MDMBA, Rabin Niroula, MBBS, John Vatkevich, Jordan Robison, CRA, Ilyas Sahin, MD, Chelsea D Mullins, BS, Patrycja M Dubielecka, PhD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-134757

Published: 2020

Journal Articles

Comparison of End-of-Life Care Quality Outcomes and Indicators of Palliative Needs between Medicare Beneficiaries with Solid and Hematologic Malignancies

Pamela C Egan, MD, Emmanuelle Belanger, PhD, Orestis A. Panagiotou, MD PhD, Vinay B Rao, Aryeh Pelcovits, MD, Thomas W. LeBlanc, MDMA,MS, Adam J Olszewski, MD

Blood (2020) 136 (Supplement 1): 11.

https://doi.org/10.1182/blood-2020-143078

Published: 2020

Journal Articles

Vincristine Sulfate Liposome Injection (VSLI) with Bendamustine and Rituximab As First-Line Therapy for Indolent B-Cell Lymphomas: A Phase 1 Study

Thomas A Ollila, MD, James Butera, MD, Pamela C Egan, MD, John L Reagan, MD, Anthony G Thomas, DO, Inna Yakirevich, NP, Kelsey MacKinnon, Jeannine Margolis, Valerie Rosati, Jessica McMahon, RN, Jordan Robison, CRA, Adam J Olszewski, MD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-134054

Published: 2020

Journal Articles

Evaluating the Incidence of Cardiovascular and Thrombotic Events in Secondary Polycythemia

Clara Mao, BS, Adam J Olszewski, MD, Pamela C Egan, MD, Peter Barth, MD, John L Reagan, MD

Blood (2019) 134 (Supplement_1): 3511.

https://doi.org/10.1182/blood-2019-122943

Published: 2019

Journal Articles

Billed Palliative Care Services and End-of-Life Care in Patients with Hematologic Malignancies

Vinay B Rao, Emmanuelle Belanger, PhD, Pamela C Egan, MD, Thomas W. LeBlanc, MDMA,MHS, Adam J Olszewski, MD

Blood (2019) 134 (Supplement_1): 384.

https://doi.org/10.1182/blood-2019-121955

Published: 2019

Journal Articles

Early Adoption and Outcomes of Ibrutinib As Treatment for Older Patients with Chronic Lymphocytic Leukemia (CLL): A Population-Based Study

Adam J Olszewski, MD, Matthew S. Davids, MD, Inna Yakirevich, NP, Pamela C Egan, MD

Blood (2019) 134 (Supplement_1): 265.

https://doi.org/10.1182/blood-2019-122516

Published: 2019

Journal Articles

BrUOG 345: Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

Adam Zayac, MD, Pamela C Egan, MD, Thomas A Ollila, MD, Adam J Olszewski, MD, Peter Barth, MD, Matthew I. Quesenberry, MD, James Butera, MD, Loren D. Fast, PhD, Rabin Niroula, MBBS, Peter J. Quesenberry, MD, John L Reagan, MD

Blood (2019) 134 (Supplement_1): 4460.

https://doi.org/10.1182/blood-2019-123789

Published: 2019

Journal Articles

Tumor-Specific Cell-Free DNA (cfDNA) in the Cerebrospinal Fluid (CSF) Detects Cytologically Occult Central Nervous System (CNS) Involvement in Aggressive Lymphomas

Adam J Olszewski, MD, Anna D Chorzalska, PhD, Diana O Treaba, MD, John L Reagan, MD, Pamela C Egan, MD, Habibe Kurt, MD, James Butera, MD, William Rafelson, MDMBA, Alexander C Mohler, MD MS, Thomas A Ollila, MD, Rabin Niroula, MBBS, Jordan Robison, CRA, Chelsea D Mullins, BS, Patrycja M Dubielecka, PhD

Blood (2019) 134 (Supplement_1): 2800.

https://doi.org/10.1182/blood-2019-125475

Published: 2019

Journal Articles

End-of-Life Care Quality Outcomes Among Medicare Beneficiaries with Hematologic Malignancies

Pamela C Egan, MD, Thomas W. LeBlanc, MD MA, Adam J Olszewski, MD

Blood (2018) 132 (Supplement 1): 829.

https://doi.org/10.1182/blood-2018-99-112692

Published: 2018

Journal Articles

Using Machine Learning to Classify the "Goodness" of Hmsc-Derived and AML-Derived EV's

Chibuikem Chukwudalu Nwizu, Lorin Crawford, PhD, Theo Borgovan, MD BS, Sicheng Wen, MD PhD, Mark S Dooner, Pamela C Egan, MD, John L. Reagan, MD, Adam J Olszewski, MD, Laura R Goldberg, MD PhD, Peter J. Quesenberry, MD

Blood (2018) 132 (Supplement 1): 5244.

https://doi.org/10.1182/blood-2018-99-120183

Published: 2018

Journal Articles

Outcomes Associated with Antimicrobial Use during High Dose Cytarabine Consolidation in Acute Myeloid Leukemia

Colin Vale, MD, Dimitrios Farmakiotis, MD, Pamela C Egan, MD, Randall Ingham, MD, John L. Reagan, MD

Blood (2018) 132 (Supplement 1): 1402.

https://doi.org/10.1182/blood-2018-99-110175

Published: 2018

Journal Articles

Survival and Risk of Central Nervous System Recurrence in Burkitt or High-Grade B-Cell Lymphoma in the DA-EPOCH-R Era

Dominic Decker, MD, Pamela C Egan, MD, Diana O Treaba, MD, Adam J Olszewski, MD

Blood (2018) 132 (Supplement 1): 2983.

https://doi.org/10.1182/blood-2018-99-115676

Published: 2018

Journal Articles

Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia

Thomas W. LeBlanc, Pamela C. Egan, Adam J. Olszewski

Blood (2018) 132 (7): 717–726.

https://doi.org/10.1182/blood-2018-03-842575

Published: 2018

Includes: Supplemental data

Journal Articles

Transfusion Dependence and Use of Hospice Among Medicare Beneficiaries with Leukemia

Adam J Olszewski, MD, Pamela C Egan, MD, Thomas W. LeBlanc, MD MA

Blood (2017) 130 (Supplement 1): 277.

https://doi.org/10.1182/blood.V130.Suppl_1.277.277

Published: 2017

NARROW

Removing Transfusion Dependence As a Barrier to Hospice Enrollment (BRUOG-407)

Whole Genome Sequencing Identifies a Recurrent Mutation in Complement Factor I ( CFI ) in Primary Myelofibrosis (PMF)

Tumor Lysis Syndrome Risk in Outpatient Versus Inpatient Administration of Venetoclax and Hypomethlators for Acute Myeloid Leukemia

Cerebrospinal Fluid (CSF) Analysis of Tumor-Specific Cell-Free DNA (cfDNA) As a Diagnostic and Prognostic Tool for Central Nervous System (CNS) Invasion in Lymphoma

Comparison of End-of-Life Care Quality Outcomes and Indicators of Palliative Needs between Medicare Beneficiaries with Solid and Hematologic Malignancies

Vincristine Sulfate Liposome Injection (VSLI) with Bendamustine and Rituximab As First-Line Therapy for Indolent B-Cell Lymphomas: A Phase 1 Study

Evaluating the Incidence of Cardiovascular and Thrombotic Events in Secondary Polycythemia

Billed Palliative Care Services and End-of-Life Care in Patients with Hematologic Malignancies

Early Adoption and Outcomes of Ibrutinib As Treatment for Older Patients with Chronic Lymphocytic Leukemia (CLL): A Population-Based Study

BrUOG 345: Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

Tumor-Specific Cell-Free DNA (cfDNA) in the Cerebrospinal Fluid (CSF) Detects Cytologically Occult Central Nervous System (CNS) Involvement in Aggressive Lymphomas

End-of-Life Care Quality Outcomes Among Medicare Beneficiaries with Hematologic Malignancies

Using Machine Learning to Classify the "Goodness" of Hmsc-Derived and AML-Derived EV's

Outcomes Associated with Antimicrobial Use during High Dose Cytarabine Consolidation in Acute Myeloid Leukemia

Survival and Risk of Central Nervous System Recurrence in Burkitt or High-Grade B-Cell Lymphoma in the DA-EPOCH-R Era

Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia

Transfusion Dependence and Use of Hospice Among Medicare Beneficiaries with Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only